April 17, 2011
One of the most contentious parts of the current budget debate in Washington, D.C., is whether to cut funding for planned Parenthood, a national chain that specializes in providing affordable reproductive health care for men and women. Among those who are anxiously awaiting the outcome of that debate is Karrie Galloway, CEO of planned Parenthood [...]
Read the full article →
April 17, 2011
RegeneRx Biopharmaceuticals, inc. (OTC Bulletin Board: RGRX) (“the Company” or “RegeneRx”) has announced that researchers have found that a fragment of T?4 has the ability to inhibit a type of liver cell responsible for fibrosis and scar formation by blocking the binding of AKT to actin. AKT is an important enzyme that regulates cell death; [...]
Read the full article →